PLK1 as a potential drug target in cancer therapy-Reference-Cited by-同舟云学术

PLK1 as a potential drug target in cancer therapy

Published:2004-08 Issue:4 Volume:62 Page:349-361
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Goh Kee Chuan,Wang Haishan,Yu Niefang,Zhou Yifa,Zheng Yin,Lim ZeYi,Sangthongpitag Kanda,Fang Lijuan,Du Mark,Wang Xukun,Jefferson A. B.,Rose Janet,Shamoon Blanche,Reinhard Christoph,Carte Brad,Entzeroth Michael,Ni BinHui,Taylor Marcia L.,Stünkel Walter

Publisher

Wiley

Subject

Drug Discovery

Reference29 articles.

1. Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer;Ahmad;FASEB J,2004

2. Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation;Ando;J Biol Chem,2004

3. The synthesis of pyrimido[4,5-c]pyridazine and pyrido[2,3-d]pyrimidines related to toxoflavin and fervenulin;Billings;J Heterocycl Chem,1975

4. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma;Chen;Cancer,2003

5. The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex;Cheng;EMBO J,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AHL-Based Quorum Sensing Regulates the Biosynthesis of a Variety of Bioactive Molecules in Bacteria;Journal of Natural Products;2024-02-23

2. Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibition;Acta Pharmacologica Sinica;2022-07-15

3. Suppressive Effects of EGCG on Cervical Cancer;Molecules;2018-09-12

4. Synthesis and anticancer evaluation of some novel pyrimido[5,4-e][1,2,4]triazines and pyrazolo[3,4-d]pyrimidine using DMF-DMA as methylating and cyclizing agent;Chemistry Central Journal;2018-05-23

5. Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in hela cells;Biopolymers;2014-11